The effectiveness of laser vitreolysis for vitreous floaters in posterior vitreous detachment
- PMID: 35918966
- PMCID: PMC9672707
- DOI: 10.4103/ijo.IJO_3198_21
The effectiveness of laser vitreolysis for vitreous floaters in posterior vitreous detachment
Abstract
Purpose: To determine the effectiveness of laser vitreolysis in terms of contrast sensitivity function (CSF) and vision-related quality of life (VRQol) for symptomatic floaters due to posterior vitreous detachment (PVD).
Materials: This is an interventional study that involved 57 eyes of 45 patients with symptomatic floaters for more than 3 months. Patients underwent one to three sessions of vitreolysis via Neodymiun-doped Yttrium Aluminum Garnet (Nd:YAG) laser. We examined the CSF using the computer programs Freiburg Acuity and Contrast Test (FrACT) and VRQoL survey using the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) before, and 1 month after, vitreolysis.
Results: Twelve patients had both eyes lasered and 33 patients had one eye lasered. The mean CSF improved from 3.20 ± 0.85%W to 2.64 ± 0.63%W 1 month after vitreolysis. Each use of the laser showed a significant mean difference in CSF (%W) as analyzed by paired t-test before and after the first laser (0.29 ± 0.49%W [P ≤ 0.001]); after the first and second laser (0.35 ± 0.53%W [P = 0.01]); and after second and third laser (0.21 ± 0.31%W [P = 0.02]). There was improvement in the median of four subscales in NEI VFQ-25 scores post treatment: general vision (z = -3.30, P = 0.001), near activity (z = 3.396, P = 0.001, distance activity (z = -2.788, P = 0.005), and mental health (z = -2.219, P = 0.026). The mean scores increased to 79.55 ± 9.45 from the baseline 75.06 ± 9.69 (P ≤ 0.001). No adverse events were recorded 1 month after the laser treatments.
Conclusion: Vitreolysis by Nd:YAG laser improved the CFS and VRQoL in symptomatic PVD patients.
Keywords: Contrast sensitivity function; floaters; laser vitreolysis; neodymiun-doped yttrium aluminum garnet laser; posterior vitreous detachment.
Conflict of interest statement
None
Figures


Similar articles
-
Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.Ophthalmology. 2019 Nov;126(11):1517-1526. doi: 10.1016/j.ophtha.2019.06.021. Epub 2019 Jun 22. Ophthalmology. 2019. PMID: 31471088 Free PMC article.
-
YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.JAMA Ophthalmol. 2017 Sep 1;135(9):918-923. doi: 10.1001/jamaophthalmol.2017.2388. JAMA Ophthalmol. 2017. PMID: 28727887 Free PMC article. Clinical Trial.
-
Objective assessment of YAG laser vitreolysis in patients with symptomatic vitreous floaters.Int J Retina Vitreous. 2020 Jan 21;6:1. doi: 10.1186/s40942-019-0205-8. eCollection 2020. Int J Retina Vitreous. 2020. PMID: 31988795 Free PMC article.
-
Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption.Surv Ophthalmol. 2020 Sep-Oct;65(5):589-591. doi: 10.1016/j.survophthal.2020.02.007. Epub 2020 Mar 3. Surv Ophthalmol. 2020. PMID: 32135173 Review.
-
Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.Adv Ther. 2020 Apr;37(4):1319-1327. doi: 10.1007/s12325-020-01261-w. Epub 2020 Feb 21. Adv Ther. 2020. PMID: 32086749 Free PMC article. Review.
References
-
- Huang LC, Yee KMP, Wa CA, Nguyen JN, Sadun AA, Sebag J. V. B.8. Vitreous Floaters and Vision:Current Concepts and Management Paradigms. 2014:771–88. 10.1007/978-1-4939-1086-1_45.